Share on StockTwits

The Liberian government says it will receive doses of an experimental Ebola drug to treat doctors in the West African country. The U.S. government confirmed that it had put Liberian officials in touch with the maker of ZMapp, and referred additional questions to Mapp Biopharmaceutical Inc. It was unclear how much of the treatment would be sent but government officials cautioned that the company had only a limited supply of the drug. Thus far, two Americans and a Spaniard have received the drug.

“Liberian Doctors To Get Experimental Ebola Drug” is categorized as “world”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.